Arkolith/Insider Trading/RLAY/Form 4

Catinazzo Thomas

Chief Financial OfficerRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Apr 30, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$59K
Net Open-Market Flow
-$59K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 30, 2025Sell(S)13K$3.00$39K355K
Apr 29, 2025Sell(S)4K$3.23$11K368K
Apr 28, 2025Sell(S)981$3.17$3K372K
Apr 28, 2025Sell(S)2K$3.17$5K373K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-061366) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML